New York State Common Retirement Fund
DMAC icon

New York State Common Retirement Fund’s DiaMedica Therapeutics DMAC Stock Holding History

New York State Common Retirement Fund’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6K Hold
2,781
– – ﹤0.01% 3125
2026
Q1 		$18.8K Sell
2,781
-9,019
-76% -$71.5K ﹤0.01% 3017
2025
Q4 		$93.9K Hold
11,800
– – ﹤0.01% 2630
2025
Q3 		$81.1K Sell
11,800
-14,500
-55% -$78.7K ﹤0.01% 2739
2025
Q2 		$103K Buy
+26,300
New +$103K ﹤0.01% 2615

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

New York State Common Retirement Fund's DMAC Position: Q2 2026 in Review

New York State Common Retirement Fund held its DiaMedica Therapeutics (DMAC) position steady in Q2 2026 at 2,781 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3125.

New York State Common Retirement Fund first reported a position in DMAC in Q2 2025 and has held it in 5 quarters since. The position peaked at $103K in Q2 2025. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • New York State Common Retirement Fund held 2,781 shares of DiaMedica Therapeutics worth $19.6K as of Q2 2026.
  • New York State Common Retirement Fund left its DiaMedica Therapeutics share count unchanged in Q2 2026.
  • DiaMedica Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #3125 holding.
  • New York State Common Retirement Fund first reported a position in DiaMedica Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • New York State Common Retirement Fund's DiaMedica Therapeutics position peaked at $103K in Q2 2025.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.